Both companies have made their products available on Azure, and Curoverse is collaborating with Microsoft on benchmarking tools for analysis pipelines.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.